Summit Global Investments - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$303
-94.4%
11,179
-93.6%
0.02%
-94.4%
Q2 2023$5,363
+5.3%
174,450
+23.4%
0.36%
-9.9%
Q1 2023$5,094
-6.7%
141,381
+2.3%
0.39%
-14.5%
Q4 2022$5,462
-99.9%
138,200
+0.4%
0.46%
-9.8%
Q3 2022$5,530,000
-5.0%
137,619
-0.6%
0.51%
-0.4%
Q2 2022$5,823,000
+12.4%
138,510
+4.2%
0.51%
+34.3%
Q1 2022$5,180,000132,9650.38%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders